(Q37760613)

22 August 2017

title

Ovulation induction in polycystic ovary syndrome. (English)

1 reference

polycystic ovary syndrome

22 August 2017

main subject

1 reference

1 reference

Tannys D R Vause

1

1 reference

22 August 2017

Anthony P Cheung

2

1 reference

22 August 2017

Sony Sierra

3

1 reference

22 August 2017

Paul Claman

4

1 reference

22 August 2017

James Graham

5

1 reference

22 August 2017

Jo-Anne Guillemin

6

1 reference

22 August 2017

Louise Lapensée

7

1 reference

22 August 2017

Sabrina Stewart

8

1 reference

22 August 2017

Benjamin Chee-Man Wong

9

1 reference

22 August 2017

Society of Obstetricians and Gynecologists of Canada

10

1 reference

22 August 2017

publication date

1 May 2010

1 reference

Journal of Obstetrics and Gynaecology Canada

22 August 2017

published in

1 reference

22 August 2017

volume

32

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

495-502

1 reference

Polycystic ovaries and associated clinical and biochemical features in young women

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Improving reproductive performance in overweight/obese women with effective weight management

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

The role of lifestyle modification in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Obesity and lifestyle management in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

The impact of obesity on reproduction in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Effect of body weight reduction on plasma androgens in obese, infertile women.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Clinical and laboratory predictors of clomiphene response

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

New advances in ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Modern use of clomiphene citrate in induction of ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

The effect of therapy initiation day on clomiphene citrate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Single luteal phase serum progesterone assay as an indicator of ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Monitoring plasma concentrations to individualize treatment with clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Development, pharmacology and clinical experience with clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

An investigation of the visual disturbances experienced by patients on clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Ovarian tumors in a cohort of infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Use of metformin in polycystic ovary syndrome: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Metformin reduces abortion in pregnant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Ovulation induction management of PCOS

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Post-Ovarian Wedge Resection Adhesive Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Evaluation of ovarian adhesion formation after laparoscopic ovarian drilling by second-look minilaparoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Retracted article: Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and Gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934504-2

7 January 2021

10.1016/S1701-2163(16)34504-2

Identifiers

DOI

0 references

1 reference